About 500 reports

Abstract: - Global Cardiovascular Disease Monitoring and Diagnostic Devices Market to Reach $3.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion...

  • Cardiovascular Disease
  • Diagnostic Imaging
  • Cardiac Management
  • World
  • China
  • United States

##.## Diagnosed Prevalent Cases of Acromegaly and Gigantism with Cardiovascular Disease

  • Cardiovascular Disease
  • Diabetes
  • Epidemiology
  • Hypertension
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

## Cardiovascular Disease

  • Drug Delivery
  • Cardiovascular Disease
  • Diabetes
  • Autoimmune Disease
  • Infectious Disease
  • North America
  • Chronic Disease Prevalence
  • Cancer Incidence

Small Molecule to Inhibit CETP for Cardiovascular Disease – Drug Profile

  • Cardiovascular Disease
  • Cholesterol
  • Drug Development
  • Pharmaceutical
  • World
  • Cause-Specific Mortality Rate
  • Pharmaceutical Registrations

## Cardiovascular Diseases

  • Drug Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Hospital
  • APAC
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

Small Molecule to Inhibit CETP for Cardiovascular Disease – Drug Profile

  • Cardiovascular Disease
  • Cholesterol
  • Drug Development
  • Pharmaceutical
  • World
  • Diagnostic Imaging Density
  • Cause-Specific Mortality Rate

Small Molecule to Inhibit CYP##B## for Cardiovascular Disease – Drug Profile

  • Therapy
  • Cardiovascular Disease
  • Heart Failure
  • Pharmaceutical
  • World
  • Prescription Drug Sales
  • Pharmaceutical Registrations

## Cardiovascular Disease

  • Drug Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Europe
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

Report Scope: This report provides an updated review of theranostics, including materials, equipment, and strategies, and identifies current and emerging applications for theranostic products. The analyst delineates the current market status for theranostics, defines trends, and presents growth forecasts for the...

  • Cardiovascular Disease
  • Neurological Disorder
  • World

## Key Market Drivers ##.## Rising Number of Patients Suffering with Cardiovascular Diseases

  • Cardiovascular Disease
  • North America
  • Health Expenditure
  • Drug Approval

Healthcare CRO Services Market by Type (Early Phase Development, Clinical Development Services, Laboratory Services, and Consulting Services), Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, and Others), and End-User (Pharmaceutical & Biopharmaceutical Companies, Medical...

  • Healthcare
  • Pharmaceutical
  • Medical Device
  • Biopharmaceutical
  • Drug Development
  • Mental Health
  • Infectious Disease
  • Cardiovascular Disease
  • World
  • APAC
  • Europe
  • Health Expenditure

World United States Health Expenditure Cardiovascular Disease

  • Cardiovascular Disease
  • Neurology
  • Research And Development
  • Infectious Disease
  • APAC
  • Europe
  • Cause-Specific Mortality Rate
  • Mortality Rate

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global...

  • Therapy
  • Healthcare
  • Cardiovascular Disease
  • APAC
  • World
  • Europe
  • Smartphone Penetration

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), andOthers),Product Type (Software and Device), and Sales Channel (Business-to-Business(B2B) and Business-to-Consumer (B2C)):...

  • Therapy
  • Healthcare
  • Cardiovascular Disease
  • Europe
  • Smartphone Penetration

Monoclonal Antibodies to Inhibit Marinobufagenin for Cardiovascular Diseases – Drug Profile

  • Therapy
  • Cardiovascular Disease
  • World
  • Drug Approval
  • Health Provider Density

Abstract: - The global market for Cardiac Ablation is projected to reach US$1.4 billion by 2025, driven by the growing burden of cardiovascular diseases worldwide. Apart from circulatory disorders caused by high blood pressure and coronary artery disease such as blockages in arteries, electrical disorders, also known as...

  • Cardiovascular Disease
  • Cardiology
  • World

World Cardiovascular Disease Stroke Chronic Disease

  • Cardiovascular Disease
  • Pharmaceutical
  • World
  • Europe
  • North America
  • APAC
  • South America
  • South Africa
  • Mortality Rate
  • Elderly Population

Increase in Prevalence of Cardiovascular Diseases Rise in Geriatric Population

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Smoking Prevalence
  • Cause-Specific Mortality Rate

Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG. The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion...

  • Diabetes
  • Cardiovascular Disease
  • Chronic Disease
  • World
  • United States
  • Wearables Sales

Monoclonal Antibodies to Inhibit Marinobufagenin for Cardiovascular Diseases – Drug Profile

  • Therapy
  • Drug Development
  • Cardiovascular Disease
  • World
  • Drug Approval
  • Health Provider Density

The Global Digital Therapeutic (DTx) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing focus on preventive healthcare, unexplored therapeutic applications and large undiagnosed...

  • Pharmaceutical
  • Musculoskeletal Disorder
  • Neurology
  • Addiction Disorder
  • Respiratory Disease
  • Smoking Cessation
  • Cardiovascular Disease
  • Gastrointestinal Drug
  • Diabetes
  • World

FIGURE ## CARDIOVASCULAR DISEASE: CLINICAL TRIALS

  • Cell Therapy
  • Cardiovascular Disease
  • Clinical Trial
  • APAC
  • North America
  • Europe
  • Chronic Disease Prevalence
  • Cancer Incidence

PIPELINE ANALYSIS – CARDIOVASCULAR DISEASES

  • Cardiovascular Disease
  • Cardiovascular Drug
  • In-Store Retail
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Cause-Specific Mortality Rate
  • Elderly Population

World United States Cardiovascular Disease

  • Pharmaceutical
  • Infectious Disease
  • Biopharmaceutical
  • Monoclonal Antibody
  • Injectable Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Protein Therapy
  • World
  • APAC
  • Europe
  • Africa
  • South Africa
  • Drug Approval
  • Diabetes Prevalence

APAC Cardiovascular Disease

  • Cardiovascular Disease
  • Pharmaceutical
  • Blood Disease
  • Compression Therapy
  • World
  • Europe
  • APAC
  • Africa
  • South Africa
  • Health Expenditure
  • Mortality Rate

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application, By Region, And Segment Forecasts, 2020 - 2027 The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027.,...

  • Cardiovascular Disease
  • World
  • Overweight Prevalence
  • Drug Approval

Deaths due to Various Cardiovascular Diseases (%), United States, 2018

  • Pharmaceutical
  • Drug Development
  • Biotechnology
  • Pathology
  • Cardiovascular Disease
  • World
  • Europe
  • APAC
  • North America
  • Cause-Specific Mortality Rate
  • Drug Approval

Report Scope: This report examines the current and projected market potential of drug-eluting stents.It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through...

  • Implantable Delivery
  • Cardiovascular Disease
  • Medical Device
  • World
  • United States
  • Overweight Prevalence

Global Cardiovascular Partnering 2014 to 2021 provides the full collection of Cardiovascular disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Cardiovascular partnering deals Financial deal terms for headline, upfront and royalty by stage of development Cardiovascular...

  • Cardiology
  • Cardiovascular Disease
  • World

‘Homozygous familial hypercholesterolemia (HoFH) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Homozygous familial hypercholesterolemia (HoFH) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Homozygous...

  • Cardiovascular Disease
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom